Cargando…

Polymorphism A118G of opioid receptor mu 1 (OPRM1) is associated with emergence of suicidal ideation at antidepressant onset in a large naturalistic cohort of depressed outpatients

Antidepressants have been the object of an international controversy for about thirty years. Some patients are inclined to develop suicidal ideation (SI) at antidepressant onset; this phenomenon is known as Treatment Emergent Suicidal Ideation (TESI), and it has conducted regulatory bodies to prompt...

Descripción completa

Detalles Bibliográficos
Autores principales: Nobile, B., Ramoz, N., Jaussent, I., Gorwood, Ph, Olié, E., Castroman, J. Lopez, Guillaume, S., Courtet, Ph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385304/
https://www.ncbi.nlm.nih.gov/pubmed/30796320
http://dx.doi.org/10.1038/s41598-019-39622-3
_version_ 1783397173410398208
author Nobile, B.
Ramoz, N.
Jaussent, I.
Gorwood, Ph
Olié, E.
Castroman, J. Lopez
Guillaume, S.
Courtet, Ph
author_facet Nobile, B.
Ramoz, N.
Jaussent, I.
Gorwood, Ph
Olié, E.
Castroman, J. Lopez
Guillaume, S.
Courtet, Ph
author_sort Nobile, B.
collection PubMed
description Antidepressants have been the object of an international controversy for about thirty years. Some patients are inclined to develop suicidal ideation (SI) at antidepressant onset; this phenomenon is known as Treatment Emergent Suicidal Ideation (TESI), and it has conducted regulatory bodies to prompt warnings on antidepressants. Since, few studies have explored the pharmacogenomics of TESI. Given the growing body of evidence connecting the opioidergic system with suicidal behavior (particularly mu opioid receptor (MOR)), we decided to examine the relationship between two genetic polymorphisms (SNPs) in the opioidergic system and TESI in a sample of 3566 adult depressed outpatients. General practitioners and psychiatrists throughout France followed participants for 6 weeks after an initial prescription of tianeptine, an antidepressant treatment with mu agonism. Suicidal ideation was assessed with the item 10 of the Montgomery-Asberg Depression Rating Scale (item dedicated to SI) at baseline, and after 2 weeks, 4 weeks and 6 weeks. We analysed rs1799971 from the OPRM1 gene and rs105660 from the OPRK1 gene. Within the sample, 112 patients reported TESI while 384 did not. We found a significant association between AA genotype of rs1799971 and TESI even after adjustment for potential cofounders (OR = 1.93, 95% CI = [1.07; 3.49]; p-value = 0.03). On the other hand there were no significant association between rs1799971 and rs105560 with worsening of suicidal ideation or lifetime suicide attempts. Nevertheless, our results suggest a possible involvement of opioidergic system in TESI.
format Online
Article
Text
id pubmed-6385304
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63853042019-02-27 Polymorphism A118G of opioid receptor mu 1 (OPRM1) is associated with emergence of suicidal ideation at antidepressant onset in a large naturalistic cohort of depressed outpatients Nobile, B. Ramoz, N. Jaussent, I. Gorwood, Ph Olié, E. Castroman, J. Lopez Guillaume, S. Courtet, Ph Sci Rep Article Antidepressants have been the object of an international controversy for about thirty years. Some patients are inclined to develop suicidal ideation (SI) at antidepressant onset; this phenomenon is known as Treatment Emergent Suicidal Ideation (TESI), and it has conducted regulatory bodies to prompt warnings on antidepressants. Since, few studies have explored the pharmacogenomics of TESI. Given the growing body of evidence connecting the opioidergic system with suicidal behavior (particularly mu opioid receptor (MOR)), we decided to examine the relationship between two genetic polymorphisms (SNPs) in the opioidergic system and TESI in a sample of 3566 adult depressed outpatients. General practitioners and psychiatrists throughout France followed participants for 6 weeks after an initial prescription of tianeptine, an antidepressant treatment with mu agonism. Suicidal ideation was assessed with the item 10 of the Montgomery-Asberg Depression Rating Scale (item dedicated to SI) at baseline, and after 2 weeks, 4 weeks and 6 weeks. We analysed rs1799971 from the OPRM1 gene and rs105660 from the OPRK1 gene. Within the sample, 112 patients reported TESI while 384 did not. We found a significant association between AA genotype of rs1799971 and TESI even after adjustment for potential cofounders (OR = 1.93, 95% CI = [1.07; 3.49]; p-value = 0.03). On the other hand there were no significant association between rs1799971 and rs105560 with worsening of suicidal ideation or lifetime suicide attempts. Nevertheless, our results suggest a possible involvement of opioidergic system in TESI. Nature Publishing Group UK 2019-02-22 /pmc/articles/PMC6385304/ /pubmed/30796320 http://dx.doi.org/10.1038/s41598-019-39622-3 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Nobile, B.
Ramoz, N.
Jaussent, I.
Gorwood, Ph
Olié, E.
Castroman, J. Lopez
Guillaume, S.
Courtet, Ph
Polymorphism A118G of opioid receptor mu 1 (OPRM1) is associated with emergence of suicidal ideation at antidepressant onset in a large naturalistic cohort of depressed outpatients
title Polymorphism A118G of opioid receptor mu 1 (OPRM1) is associated with emergence of suicidal ideation at antidepressant onset in a large naturalistic cohort of depressed outpatients
title_full Polymorphism A118G of opioid receptor mu 1 (OPRM1) is associated with emergence of suicidal ideation at antidepressant onset in a large naturalistic cohort of depressed outpatients
title_fullStr Polymorphism A118G of opioid receptor mu 1 (OPRM1) is associated with emergence of suicidal ideation at antidepressant onset in a large naturalistic cohort of depressed outpatients
title_full_unstemmed Polymorphism A118G of opioid receptor mu 1 (OPRM1) is associated with emergence of suicidal ideation at antidepressant onset in a large naturalistic cohort of depressed outpatients
title_short Polymorphism A118G of opioid receptor mu 1 (OPRM1) is associated with emergence of suicidal ideation at antidepressant onset in a large naturalistic cohort of depressed outpatients
title_sort polymorphism a118g of opioid receptor mu 1 (oprm1) is associated with emergence of suicidal ideation at antidepressant onset in a large naturalistic cohort of depressed outpatients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385304/
https://www.ncbi.nlm.nih.gov/pubmed/30796320
http://dx.doi.org/10.1038/s41598-019-39622-3
work_keys_str_mv AT nobileb polymorphisma118gofopioidreceptormu1oprm1isassociatedwithemergenceofsuicidalideationatantidepressantonsetinalargenaturalisticcohortofdepressedoutpatients
AT ramozn polymorphisma118gofopioidreceptormu1oprm1isassociatedwithemergenceofsuicidalideationatantidepressantonsetinalargenaturalisticcohortofdepressedoutpatients
AT jaussenti polymorphisma118gofopioidreceptormu1oprm1isassociatedwithemergenceofsuicidalideationatantidepressantonsetinalargenaturalisticcohortofdepressedoutpatients
AT gorwoodph polymorphisma118gofopioidreceptormu1oprm1isassociatedwithemergenceofsuicidalideationatantidepressantonsetinalargenaturalisticcohortofdepressedoutpatients
AT oliee polymorphisma118gofopioidreceptormu1oprm1isassociatedwithemergenceofsuicidalideationatantidepressantonsetinalargenaturalisticcohortofdepressedoutpatients
AT castromanjlopez polymorphisma118gofopioidreceptormu1oprm1isassociatedwithemergenceofsuicidalideationatantidepressantonsetinalargenaturalisticcohortofdepressedoutpatients
AT guillaumes polymorphisma118gofopioidreceptormu1oprm1isassociatedwithemergenceofsuicidalideationatantidepressantonsetinalargenaturalisticcohortofdepressedoutpatients
AT courtetph polymorphisma118gofopioidreceptormu1oprm1isassociatedwithemergenceofsuicidalideationatantidepressantonsetinalargenaturalisticcohortofdepressedoutpatients